Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ascentage Pharma Group International (HK:6855)
HKEX:6855
Holding HK:6855?
Track your performance easily
Earnings Data
Report Date
Mar 26, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
―Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---
Ascentage Pharma Group International (HK:6855) Earnings, Revenues Date & History
HK:6855 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
HK:6855 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Aug 22, 2024 | HK$27.90 | HK$27.85 | -0.18% |
| Mar 27, 2024 | HK$21.95 | HK$21.95 | 0.00% |
| Aug 21, 2023 | HK$24.35 | HK$24.45 | +0.41% |
| Mar 22, 2023 | HK$23.75 | HK$23.00 | -3.16% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Ascentage Pharma Group International (HK:6855) report earnings?
Ascentage Pharma Group International (HK:6855) is schdueled to report earning on Mar 26, 2025, TBA Not Confirmed.
What is Ascentage Pharma Group International (HK:6855) earnings time?
Ascentage Pharma Group International (HK:6855) earnings time is at Mar 26, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Ascentage Pharma Group International stock?
The P/E ratio of Ascentage Pharma Group International is N/A.
What is HK:6855 EPS forecast?
Currently, no data Available
---